Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8850958 | 1.00 | MEN1 (0.69) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL29064119 | 1.00 | MEN1 (0.69) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL270713 | 0.97 | MEN1 (0.68) | MEN1KMT2ATHRBHTTMAPT | |
| 1,6-Hexanediol SCHEMBL8416483 | 0.97 | MEN1 (0.68) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL156817 | 0.97 | MEN1 (0.68) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2540125 | 0.97 | MEN1 (0.68) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL27809381 | 0.97 | MEN1 (0.68) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL7576909 | 0.97 | TSHR (0.67) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL237717 | 0.97 | — | — | |
| Di(Hydroxyethyl)Ether SCHEMBL3058961 | 0.97 | TSHR (0.67) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126548-A1 | SOLUTION FOR POST ETCH RESIDUE REMOVAL (PERR) | BASF SE (DE) | 2024-06-20 | — | — | WO | claimed |
| CN-117320762-A | Packaging solution | 博士伦爱尔兰有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-6420441-B1 | DISPERSING REMOVABLE CROSSLINKED POLYMER POROGENS IN A POLYSILOXANE, CURING, AND HEATING TO REMOVE POROGEN; LOW DIELECTRIC CONSTANT; HIGH POROSITY; INSULATION MATERIALS | SHIPLEY COMPANY, L.L.C. | 2002-07-16 | — | — | US | claimed |
| CN-117320762-A | Packaging solution | 博士伦爱尔兰有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-114096567-A | Glycophospholipid polymer networks and uses thereof | 鲍希与洛姆伯股份有限公司 | 2022-02-25 | — | — | CN | disclosed |
| US-20210179519-A1 | COMPOUND, SYNTHESIS METHOD OF THE COMPOUND, HARDMASK COMPOSITION, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| EP-2913142-B1 | TUBE FOR HEAT EXCHANGER | HARIMA CHEMICALS INC (JP) | 2018-12-19 | — | — | EP | disclosed |
| US-10092983-B2 | Brazing composition, heat exchanger tube, and heat exchanger | HARIMA CHEMICALS, INCORPORATED (JP) | 2018-10-09 | — | — | US | disclosed |
| EP-1874878-B1 | PROCESS FOR THE COATING OF METALLIC COMPONENTS WITH AN AQUEOUS ORGANIC COMPOSITION | CHEMETALL GMBH (DE) | 2017-07-12 | — | — | EP | disclosed |
| US-9365727-B2 | Process for the coating of metallic components with an aqueous organic composition | CHEMETALL GMBH (DE) | 2016-06-14 | — | — | US | disclosed |
| EP-2913142-A1 | BRAZING COMPOSITION, TUBE FOR HEAT EXCHANGER, AND HEAT EXCHANGER | Harima Chemicals, Inc. (JP) | 2015-09-02 | — | — | EP | disclosed |
| EP-1114737-A1 | BIAXIALLY ORIENTED POLYESTER FILM FOR THERMAL TRANSFER RIBBON | TEIJIN LIMITED (JP) | 2001-07-11 | — | — | EP | disclosed |
| US-6113815-A | HYDROLYSIS RESISTANCE | BIOSHIELD TECHNOLOGIES, INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0272856-B1 | METHOD OF MANUFACTURING MOLDED PRODUCTS AND LAMINATED STRUCTURE INCLUDING THE MOLDED PRODUCTS MANUFACTURED ACCORDING TO THE METHOD | Bridgestone Corporation (JP) | 1992-07-22 | — | — | EP | disclosed |
| US-4830916-A | POLYETHERURETHANE MOLDED FOAM SOUND INSULATION | BRIDGESTONE CORPORATION (JP) | 1989-05-16 | — | — | US | disclosed |
| EP-0272856-A2 | Method of manufacturing molded products and laminated structure including the molded products manufactured according to the method | Bridgestone Corporation (JP) | 1988-06-29 | — | — | EP | disclosed |
| US-4663302-A | Bicyclic amide acetal modified catalysts for polyurethane polymer formation | ASHLAND OIL (US) | 1987-05-05 | — | — | US | disclosed |
| US-4398913-A | ALKALINE PASTES | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-08-16 | — | — | US | disclosed |
| US-4386935-A | Process for producing discharge reserve prints on textile materials with amino-azo-benzene dyes | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-06-07 | — | — | US | disclosed |
| US-4332936-A | AMINE CATALYZED SUCROSE COPOLYMERIZATION | MOBAY CHEMICAL CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179519-A1 | COMPOUND, SYNTHESIS METHOD OF THE COMPOUND, HARDMASK COMPOSITION, AND METHOD OF FORMING PATTERNS | CCNK, C9, CDK10 | MEN1 972/4885KMT2A 2289/4885THRB 4712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.